Boardroom Alpha
Start trial
8-K primary document
TER · Current Report (Form 8-K) · Filed October 28, 2025

Teradyne Inc — 8-K exhibit

d12467dex991.htm
Teradyne Inc on Boardroom Alpha
EX-99.1

Exhibit 99.1

Teradyne Announces Chief Financial Officer Transition

North Reading, Mass. – October 28th, 2025 – Teradyne, Inc. (NASDAQ: TER), a leading provider of automated test equipment and advanced robotics, today announced that Michelle Turner has been appointed its Chief Financial Officer effective November 3, 2025 replacing Sanjay Mehta, who has served as Teradyne’s CFO since 2019. Mr. Mehta will stay on as an executive advisor to help support capacity expansion driven by a demand in Semiconductor Test. Mr. Mehta plans to retire in 2026.

Ms. Turner brings 30 years of financial and strategic leadership experience in the technology and manufacturing sectors, and has a strong track record of driving growth, disciplined capital allocation, and operational efficiency.

“Our industry is entering a period of accelerating demand driven by advances in AI, semiconductors, and industrial automation,” said Greg Smith, President and CEO of Teradyne. “Aligning our leadership structure around these opportunities will help us execute with focus and agility. I want to thank Sanjay for his excellent leadership and contributions over the past six years and I’m glad that we will have the benefit of his guidance as we expand capacity in 2026. I’m excited to welcome Michelle to the Teradyne team. Her broad, diverse experiences and strong track record of financial leadership will add critical strength to our team.”

Ms. Turner added: “I am thrilled to join the company during such an exciting time of growth and strategic opportunity. I look forward to joining the leadership team and leading the finance organization as we build on the company’s success and drive long-term shareholder returns.”

Ms. Turner’s experience as a senior financial executive spans the aerospace & defense, industrial, healthcare, and oil & gas industries. Prior to joining Teradyne, she was the Chief Financial Officer for L3Harris Technologies, a defense technology company. Prior to L3Harris Technologies, Ms. Turner held a variety of senior financial management and leadership roles in Johnson & Johnson, BHP Billiton, Raytheon, and Honeywell.

Ms. Turner received her bachelor’s degree in accounting from the University of South Florida and her MBA from Arizona State.

About Teradyne

Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne’s customers to consistently deliver on their quality standards. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

For more information, contact:

Amy McAndrews

Investor Relations

Tel 978.370.3945

Investor.relations@teradyne.com

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer